Julia Stockmann
Bochum, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 25, 2022
Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical Alzheimer's disease risk: Results from a prospective cohort followed over 17 years.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 27, 2021
Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.
Journal: Alzheimer's research & therapy
Published: January 16, 2021
Genetic predisposition, Aβ misfolding in blood plasma, and Alzheimer's disease.
Journal: Translational psychiatry
Published: November 16, 2020
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.
Journal: Alzheimer's research & therapy
Published: August 06, 2020
The Effect of (-)-Epigallocatechin-3-Gallate on the Amyloid-β Secondary Structure.
Journal: Biophysical journal
Published: October 28, 2019
Discovery of three novel sesquiterpene synthases from Streptomyces chartreusis NRRL 3882 and crystal structure of an α-eudesmol synthase.
Journal: Journal of biotechnology
Published: January 14, 2019
Transcriptome profiling of the Australian arid-land plant Eremophila serrulata (A.DC.) Druce (Scrophulariaceae) for the identification of monoterpene synthases.
Journal: Phytochemistry
Published: November 07, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026